Results 51 to 60 of about 202 (90)

Attributable mortality to healthcare-associated infections: a comprehensive nationwide assessment in Spain, 2022 and 2023. [PDF]

open access: yesEuro Surveill
Cantero M   +6 more
europepmc   +1 more source

Long-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeks. [PDF]

open access: yesJ Antimicrob Chemother
Suárez-García I   +12 more
europepmc   +1 more source

Genotyping, sequencing and analysis of 140,000 adults from Mexico City. [PDF]

open access: yesNature, 2023
Ziyatdinov A   +48 more
europepmc   +1 more source

Determinants of long-acting cabotegravir plus rilpivirine discontinuation in real-world HIV care: insights from the relativity cohort. [PDF]

open access: yesAIDS
Troya J   +25 more
europepmc   +1 more source

Lung function and radiological findings 1 year after COVID-19: a prospective follow-up. [PDF]

open access: yesRespir Res, 2022
Tarraso J   +17 more
europepmc   +1 more source

Fatigue in pediatric patients with inflammatory bowel disease: a multicenter study by the SEGHNP. [PDF]

open access: yesCrohns Colitis 360
Martin-Masot R   +8 more
europepmc   +1 more source

Edoxaban Safety and Effectiveness in Real-Life Patients with Heart Failure and Atrial Fibrillation: EMAYIC Study. [PDF]

open access: yesJ Clin Med
Salguero-Bodes R   +9 more
europepmc   +1 more source

HLA class-I genotyping to personalize Bacille Calmette-Guerin immunotherapy in bladder cancer. [PDF]

open access: yesOncoimmunology
Ruiz-Lorente I   +14 more
europepmc   +1 more source

Personalized Blood Pressure Targeting After Endovascular Therapy for Acute Ischemic Stroke: A Randomized Clinical Trial.

open access: yesJAMA Neurol
Camps-Renom P   +35 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy